http://www.dakotafinancialnews.com/...ated-by-analysts-at-jpmorgan-chase-co/713894/
PMorgan Chase & Co. began coverage on shares ofMesoblast limited (NASDAQ:MESO) in a research report issued on Tuesday, The Fly reports. The brokerage set an “overweight” rating on the stock.
A number of other research firms also recently commented on MESO. Ladenburg Thalmann restated a “buy” rating on shares of Mesoblast limited in a research report on Tuesday, November 24th. Zacks Investment Research upgraded Mesoblast limited from a “hold” rating to a “buy” rating and set a $7.00 target price on the stock in a research noteon Friday.
Shares of Mesoblast limited (NASDAQ:MESO) opened at 6.09 on Tuesday. The company has a 50 day moving average of $0.00 and a 200 day moving average of $0.00. Mesoblast limited has a 1-year low of $6.02 and a 1-year high of $6.36. The company’s market cap is $406.20 million.
Could soar 171% from here, page-2
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.038(3.64%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.09 | $1.03 | $3.727M | 3.492M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 36224 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 14070 | 6 |
View Market Depth
| Last trade - 12.28pm 02/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |